Company
Headquarters: Wan Chai, Hong Kong
Employees: 2,372
HK$760.4 Million
HKD as of July 1, 2024
US$97.3 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
China Medical & HealthCare Group Limited, an investment holding company, primarily operates hospitals in the People's Republic of China, Australia, and the Philippines. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company is also involved in the property development of independent living units; and project management of health campus with a focus on elderly care and retirement community comprising elderly nursing homes, service apartments, and independent living units, as well as a shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and land; leases residential and office properties; and provides money lending and healthcare services. Further, the company is involved in trading of medical equipment and related supplies; and securities listed in overseas exchange. The company was formerly known as COL Capital Limited and changed its name to China Medical & HealthCare Group Limited in February 2016. The company is headquartered in Wanchai, Hong Kong.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
China Medical & HealthCare Group Ltd has the following listings and related stock indices.
Stock: HKEX: 0383 wb_incandescent
Stock: FSX: SMIF wb_incandescent